Evidence map›Paper›PMID 42088432›Full record

ArticleInternational journal of biological sciences2026

SLC4A7 Drives NSCLC Progression and Immune Evasion via pH Dysregulation: Its Targeting Synergizes with Anti-PD-1/L1 Therapy.

Hao Qin, Dongfang Tang, Zheng Li, Fuzhi Yang, Jing Wang, Xiucheng Liu, Chang Chen, Wen Gao

Abstract read
In one paragraph

Article in International journal of biological sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Recent progress in small molecules targeting the acidic tumor microenvironment.Journal of enzyme inhibition and medicinal chemistry · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hao QinDepartment of Thoracic Surgery, Huadong Hospital, Fudan University, Shanghai, 200041, China.
Dongfang TangDepartment of Thoracic Surgery, Huadong Hospital, Fudan University, Shanghai, 200041, China.
Zheng LiDepartment of Thoracic Surgery, Huadong Hospital, Fudan University, Shanghai, 200041, China.
Fuzhi YangDepartment of Thoracic Surgery, Huadong Hospital, Fudan University, Shanghai, 200041, China.
Jing WangDepartment of Thoracic Surgery, Huadong Hospital, Fudan University, Shanghai, 200041, China.
Xiucheng LiuDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China.
Chang ChenDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China.
Wen GaoDepartment of Thoracic Surgery, Huadong Hospital, Fudan University, Shanghai, 200041, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solid tumors create an acidic tumor microenvironment (TME) that drives cancer progression, therapy resistance, and immune evasion. Bicarbonate is crucial for maintaining acid-base balance, however, its role in non-small cell lung cancer (NSCLC) remains unclear. Through the analysis of single-cell RNA sequencing data and the TCGA and CPTAC databases, we identified solute carrier family 4 member 7 (SLC4A7) as the predominantly expressed bicarbonate transporter in NSCLC. Functionally, SLC4A7 knockdown impaired bicarbonate uptake, resulting in intracellular acidification and extracellular alkalinization. This phenomenon led to a decrease in glycolysis and subsequently suppressed the growth and metastasis of NSCLC. Both

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsSodium-Bicarbonate SymportersAnimalsCell Line, TumorHumansHydrogen-Ion ConcentrationImmune Checkpoint InhibitorsMiceTumor MicroenvironmentImmune Checkpoint InhibitorsSLC4A7 protein, humanSodium-Bicarbonate Symportersbicarbonate transporterimmunotherapynon-small cell lung cancertumor microenvironment

Identifiers

PMID42088432
PMCPMC13137449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.